Your browser doesn't support javascript.
loading
Predictive value of p53 and AXL immunostaining for the efficacy of immune checkpoint inhibitor-based therapy after osimertinib treatment in patients with epidermal growth factor-mutant non-small cell lung cancer.
Morimoto, Kenji; Yamada, Tadaaki; Sawada, Ryo; Azuma, Koichi; Goto, Yasuhiro; Harada, Taishi; Shiotsu, Shinsuke; Tamiya, Nobuyo; Chihara, Yusuke; Takeda, Takayuki; Hiranuma, Osamu; Hasegawa, Isao; Tanaka, Satomi; Yoshimura, Akihiro; Iwasaku, Masahiro; Tokuda, Shinsaku; Kim, Young Hak; Takayama, Koichi.
  • Morimoto K; Department of Pulmonary Medicine, Graduate School of Medical Science, Kyoto Prefectural University of Medicine, Kajii-Cho, Kamigyo-Ku, Kyoto, Japan.
  • Yamada T; Department of Pulmonary Medicine, Graduate School of Medical Science, Kyoto Prefectural University of Medicine, Kajii-Cho, Kamigyo-Ku, Kyoto, Japan. tayamada@koto.kpu-m.ac.jp.
  • Sawada R; Department of Pulmonary Medicine, Graduate School of Medical Science, Kyoto Prefectural University of Medicine, Kajii-Cho, Kamigyo-Ku, Kyoto, Japan.
  • Azuma K; Division of Respirology, Neurology, and Rheumatology, Department of Internal Medicine, Kurume University School of Medicine, Fukuoka City, Japan.
  • Goto Y; Department of Respiratory Medicine, Fujita Health University School of Medicine, Aichi, Japan.
  • Harada T; Department of Medical Oncology, Fukuchiyama City Hospital, Kyoto, Japan.
  • Shiotsu S; Department of Respiratory Medicine, Japanese Red Cross Kyoto Daiichi Hospital, Kyoto, Japan.
  • Tamiya N; Department of Pulmonary Medicine, Rakuwakai Otowa Hospital, Kyoto, Japan.
  • Chihara Y; Department of Respiratory Medicine, Uji-Tokushukai Medical Center, Kyoto, Japan.
  • Takeda T; Department of Respiratory Medicine, Japanese Red Cross Kyoto Daini Hospital, Kyoto, Japan.
  • Hiranuma O; Department of Pulmonary Medicine, Otsu City Hospital, Shiga, Japan.
  • Hasegawa I; Department of Pulmonary Medicine, Saiseikai Shiga Hospital, Shiga, Japan.
  • Tanaka S; Department of Pulmonary Medicine, Graduate School of Medical Science, Kyoto Prefectural University of Medicine, Kajii-Cho, Kamigyo-Ku, Kyoto, Japan.
  • Yoshimura A; Department of Pulmonary Medicine, Graduate School of Medical Science, Kyoto Prefectural University of Medicine, Kajii-Cho, Kamigyo-Ku, Kyoto, Japan.
  • Iwasaku M; Department of Pulmonary Medicine, Graduate School of Medical Science, Kyoto Prefectural University of Medicine, Kajii-Cho, Kamigyo-Ku, Kyoto, Japan.
  • Tokuda S; Department of Pulmonary Medicine, Graduate School of Medical Science, Kyoto Prefectural University of Medicine, Kajii-Cho, Kamigyo-Ku, Kyoto, Japan.
  • Kim YH; Department of Pulmonary Medicine, Graduate School of Medical Science, Kyoto Prefectural University of Medicine, Kajii-Cho, Kamigyo-Ku, Kyoto, Japan.
  • Takayama K; Department of Pulmonary Medicine, Graduate School of Medical Science, Kyoto Prefectural University of Medicine, Kajii-Cho, Kamigyo-Ku, Kyoto, Japan.
Cancer Immunol Immunother ; 72(6): 1699-1707, 2023 Jun.
Article en En | MEDLINE | ID: mdl-36617602
Asunto(s)
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Search on Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Carcinoma de Pulmón de Células no Pequeñas / Neoplasias Pulmonares Tipo de estudio: Observational_studies / Prognostic_studies / Risk_factors_studies Límite: Humans Idioma: En Año: 2023 Tipo del documento: Article
Texto completo
Imprimir
XML
PubMed Links
Search on Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Carcinoma de Pulmón de Células no Pequeñas / Neoplasias Pulmonares Tipo de estudio: Observational_studies / Prognostic_studies / Risk_factors_studies Límite: Humans Idioma: En Año: 2023 Tipo del documento: Article